摘要
炎症性肠病是一种累及胃肠道的慢性疾病,目前主要治疗药物如氨基水杨酸制剂和免疫抑制剂均有一定的局限性。英夫利昔等多种生物制剂的使用,临床已取得可靠疗效,为患者带来更多治疗机会。随着对炎症性肠病发病机制认识的不断深入,针对免疫功能异常的新的治疗手段也越来越被人们所接受和使用,本文就目前IBD的生物免疫治疗进展做一综述。
Inflammatory bowel disease is chronic disease, which affects the gastrointestinal tract mainly. The drugs used for IBD now, such as amino salicylic acid preparation and immunosuppressive agent, have some limitations. The better understanding of the mechanisms of inflammatory bowel disease has driven our progress into the development of new biological therapies targeting specific molecules. Aim of this article is to review the biological compounds and their efficacy in IBD.
出处
《医学与哲学（B）》
2013年第4期7-9,47,共4页
Medicine & Philosophy(B)
关键词
炎症性肠病
临床治疗
生物免疫治疗
inflammatory bowel disease, clinical therapy, biological compounds
